Barclays analyst Andrew Mok raised the firm’s price target on Brookdale Senior Living (BKD) to $15 from $14 and keeps an Overweight rating on the shares. The firm adjusted targets in the healthcare facilities and managed care group as part of a preview of 2026 outlooks.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BKD:
- Brookdale Senior Living Reports Strong Occupancy Momentum Into 2026
- Brookdale Senior Living announces December occupancy of 82.4%
- Brookdale Senior Living double upgraded to Buy at BofA
- Brookdale Senior Living upgraded to Buy from Underperform at BofA
- Brookdale Senior Living announces November occupancy of 82.5%